Spectrum Pharmaceuticals Commences Phase 2 Study of ZEVALIN® in Combination with the Redox Modulating Agent Motexafin Gadolinium (MGd) - Yahoo Finance
27 May 2012, 12:13 pm
ZEVALIN (ibritumomab tiuxetan) injection for intravenous use, is indicated for the treatment of patients with relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphoma (NHL). ZEVALIN is also indicated for the treatment of ...

Discovery Expected to Shift Research Direction in Lupus and Asthma - Newswise
27 May 2012, 11:58 am
Those receiving the strongest signals become the T helper follicular cells that B cells must partner with to produce antibodies specific to the current pathogen. Those getting weaker signals become Th2 effectors that travel back to the infection site to ...

World Cup winner Johnson opens new clinical trials unit - Leicester Mercury
25 May 2012, 1:31 am
It makes a huge difference." The 57-year-old is taking part in a trial for a new treatment for follicular lymphoma after being diagnosed with an advanced form of the cancer in November. Ms Roth, said: "I was offered the chance try out a new drug which I ...

Robotic Hair Replacement The First Of Its Kind - NY1
23 May 2012, 6:58 pm
Called the Artas System from Restoration Robotics, it was recently approved by the FDA to help with a type of hair transplantation technique called follicular unit transplantation where follicular units, groups of one to four hairs, are removed ...

BiovaxID(R) Personalized Lymphoma Vaccine is Featured in Article Published in Scrip Intelligence - Marketwatch
21 May 2012, 6:54 pm
"Biovest has been meeting with regulatory officials to make sure it has the clinical data necessary to win approval for the treatment of follicular non-Hodgkin's lymphoma. If the company's efforts are successful, it could have the first cancer ...

Struma ovarii with follicular thyroid-type carcinoma and neuroendocrine component: case report - 7thspace.com
21 May 2012, 8:38 am
Struma ovarii (SO) is a slow-growing ovarian neoplasm with thyroid tissue as itspredominant component. It is an uncommon neoplasm, usually asymptomatic with anunknown risk of malignant transformation. Due to difficulties in assessing the rare ...

Spectrum Pharmaceuticals Commences Phase 2 Study of ZEVALIN in Combination with the Redox Modulating Agent Motexafin Gadolinium - Benzinga
17 May 2012, 5:44 am
in patients with rituximab-refractory low-grade or follicular B-cell non-Hodgkin's lymphoma (NHL). MGd is a redox modulating agent designed to selectively accumulate in cancer cells and interact with intracellular reducing metabolites, producing reactive ...

New Scientific Study Provides Evidence That Morgellons Is a Physical Illness - YAHOO!
16 May 2012, 9:34 am
Fibers from human patients were found to be biological in origin and are produced by keratinocytes in epithelial and follicular tissues. The findings are consistent with the 2012 Center for Disease Control publication stating that over 80% of non-biopsy ...

NeoGraft Scar Free Hair Restoration California Can Permanently Eliminate Balding Areas of the Mustache - YAHOO!
16 May 2012, 5:52 am
Then, using the NeoGraft hand piece, about 1 mm in diameter, individual naturally occurring follicular (hair) units, each containing from 1-5 hairs, are extracted from the scalp. By using gentle air pressure to slide out each follicular hair unit ...

Biovest plans to file BiovaxID MAA with EMA for treatment of follicular NHL - News-Medical.Net
14 May 2012, 6:23 am
Biovest International, Inc. (OTCQB:BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB:ABPI), today announced that Biovest plans to file for marketing approval in the European Union (EU) for BiovaxID®, its ...